51
|
Burdorf L, Riner A, Rybak E, Harris D, Dahi S, Zhang T, Parsell D, Ali F, Schwartz E, Kang E, Cheng X, Sievert E, Braileanu G, Quinn K, Shah A, Shah A, De Meyer S, Deckmyn H, Phelps C, Ayares D, Pierson R, Azimzadeh A. Blockade of Glycoproteins Ib and IIb/IIIa Reduces Platelet Sequestration and PVR Rise in a Xenogeneic Lung Perfusion Model. J Heart Lung Transplant 2015. [DOI: 10.1016/j.healun.2015.01.766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
52
|
Burdorf L, Rybak E, Zhang T, Harris D, Dahi S, Kubicki N, Woodall J, Parsell D, Cheng X, Schwartz E, Kang E, Sievert E, Braileanu G, Phelps C, Ayares D, Azimzadeh A, Pierson R. Extended Life-Support Duration in a Xenogeneic Lung Transplantation Model Using Pigs With Multiple Genetic Modifications. J Heart Lung Transplant 2015. [DOI: 10.1016/j.healun.2015.01.767] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
53
|
Knetsch CW, Connor TR, Mutreja A, van Dorp SM, Sanders IM, Browne HP, Harris D, Lipman L, Keessen EC, Corver J, Kuijper EJ, Lawley TD. Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011. ACTA ACUST UNITED AC 2014; 19:20954. [PMID: 25411691 DOI: 10.2807/1560-7917.es2014.19.45.20954] [Citation(s) in RCA: 154] [Impact Index Per Article: 15.4] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Farm animals are a potential reservoir for human Clostridium difficile infection (CDI), particularly PCR ribotype 078 which is frequently found in animals and humans. Here, whole genome single-nucleotide polymorphism (SNP) analysis was used to study the evolutionary relatedness of C. difficile 078 isolated from humans and animals on Dutch pig farms. All sequenced genomes were surveyed for potential antimicrobial resistance determinants and linked to an antimicrobial resistance phenotype. We sequenced the whole genome of 65 C. difficile 078 isolates collected between 2002 and 2011 from pigs (n = 19), asymptomatic farmers (n = 15) and hospitalised patients (n = 31) in the Netherlands. The collection included 12 pairs of human and pig isolates from 2011 collected at 12 different pig farms. A mutation rate of 1.1 SNPs per genome per year was determined for C. difficile 078. Importantly, we demonstrate that farmers and pigs were colonised with identical (no SNP differences) and nearly identical (less than two SNP differences) C. difficile clones. Identical tetracycline and streptomycin resistance determinants were present in human and animal C. difficile 078 isolates. Our observation that farmers and pigs share identical C. difficile strains suggests transmission between these populations, although we cannot exclude the possibility of transmission from a common environmental source.
Collapse
|
54
|
Stagg R, McKeage M, Kotasek D, Markman B, Hidalgo M, Millward M, Jameson M, Harris D, Dupont J, Hughes B. A Phase 1B Study of the Anti-Cancer Stem Cell Agent Demcizumab (Dem), Pemetrexed (Pem) & Carboplatin (Carbo) in Pts with 1St Line Non-Squamous Nsclc. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu349.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
55
|
Littman E, Phan V, Harris D, Severino M, Barton A, La A. Can mean ovarian volume be a predictor for embryo aneuploidy rate? Fertil Steril 2014. [DOI: 10.1016/j.fertnstert.2014.07.1139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
56
|
Krohn K, Kellier N, Masica D, Midkiff K, Harris D, Andrews E. Post-Marketing Case Series Study of Adult Osteosarcoma and For(s)teo: Study Findings From the First 9 Years. J Clin Densitom 2014. [DOI: 10.1016/j.jocd.2014.04.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
57
|
Burdorf L, Rybak E, Zhang T, Harris D, Dahi S, Ali F, Parsell D, Braileanu G, Cheng X, Sievert E, Phelps C, Ayares D, Azimzadeh A, Pierson R. Combined Thromboxane Synthase Inhibition and H2-Receptor Blockade Prevents PVR Elevation During GalTKO.hCD46.hCD55 Pig Lung Perfusion With Human Blood. J Heart Lung Transplant 2014. [DOI: 10.1016/j.healun.2014.01.675] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
58
|
Rees JD, Bennett AN, Harris D, Jones T. Superior outcomes for military ankylosing spondylitis patients treated with anti-TNF. J ROY ARMY MED CORPS 2014; 160:310-3. [DOI: 10.1136/jramc-2013-000156] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
|
59
|
Gooday RD, Anthony SG, Chadwick DR, Newell-Price P, Harris D, Duethmann D, Fish R, Collins AL, Winter M. Modelling the cost-effectiveness of mitigation methods for multiple pollutants at farm scale. THE SCIENCE OF THE TOTAL ENVIRONMENT 2014; 468-469:1198-1209. [PMID: 23706481 DOI: 10.1016/j.scitotenv.2013.04.078] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/06/2012] [Revised: 04/15/2013] [Accepted: 04/24/2013] [Indexed: 06/02/2023]
Abstract
Reductions in agricultural pollution are essential for meeting nationally and internationally agreed policy targets for losses to both air and water. Numerous studies quantify the impact of relevant mitigation methods by field experimentation or computer modelling. The majority of these studies have addressed individual methods and frequently also individual pollutants. This paper presents a conceptual model for the synthesis of the evidence base to calculate the impact of multiple methods addressing multiple pollutants in order to identify least cost solutions for multiple policy objectives. The model is implemented as a farm scale decision support tool that quantifies baseline pollutant losses for identifiable sources, areas and pathways and incorporates a genetic algorithm based multi-objective procedure for determining optimal suites of mitigation methods. The tool is generic as baseline losses can be replaced with measured data and the default library of mitigation methods can be edited and expanded. The tool is demonstrated through application to two contrasting farm systems, using survey data on agricultural practices typical of England and Wales. These examples show how the tool could be used to help target the adoption of mitigation options for the control of diffuse pollution from agriculture. The feedback from workshops where Farmscoper was demonstrated is included to highlight the potential role of Farmscoper as part of the farm advisory process.
Collapse
|
60
|
Harris D, Barts A, Connors J, Dahl M, Elliott T, Kong J, Keane T, Thompson D, Stafford S, Ur E, Sirrs S. Glucocorticoid-induced hyperglycemia is prevalent and unpredictable for patients undergoing cancer therapy: an observational cohort study. ACTA ACUST UNITED AC 2013; 20:e532-8. [PMID: 24311953 DOI: 10.3747/co.20.1499] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
BACKGROUND Patients with cancer are often treated with glucocorticoids (gcs) as part of therapy, which may cause hyperglycemia. We sought to define the prevalence of, and risk factors for, hyperglycemia in this setting. METHODS Adult patients taking gc as part of therapy protocols for primary brain tumour or metastasis, for lymphoma, or for bone marrow transplant (bmt) were screened with random glucometer measurements taken at least 3 hours after the last dose gcs. RESULTS We screened 90 patients [44.4% women, 55.6% men; mean age: 59.6 years (range: 25-82 years); mean body mass index (bmi): 26.4 kg/m(2) (range: 15.8-45.3 kg/m(2))] receiving gc as part of cancer treatment. Mean total daily gc dose in the group was 238.5 mg (range: 30-1067 mg) hydrocortisone equivalents. Hyperglycemia (glucose ≥ 8.0 mmol/L) was found in 58.9% (53 of 90), and diabetes mellitus (dm)-range hyperglycemia (glucose ≥ 11.1 mmol/L) in 18.9% (17 of 90). The mean time from gc ingestion to glucometer testing was 5.5 hours (range: 3-20 hours). Presence of hyperglycemia did not correlate with traditional dm risk factors such as age, sex, bmi, and personal or family history of dm. A longer interval from gc dose to testing (p < 0.05), a higher gc dose (p = 0.04), and a shorter interval between the preceding meal and testing (p = 0.02) were risk factors for hyperglycemia in some patient groups. CONCLUSIONS Glucocorticoid-induced hyperglycemia is common in patients undergoing cancer treatment and cannot be predicted by traditional risk factors for dm. We recommend that all cancer patients receiving gc be screened for hyperglycemia at least 4-6 hours after gc administration.
Collapse
|
61
|
Phan V, Littman E, Harris D, Severino M, La A. Can day 3 serum follicle stimulating hormone be a predictor for embryo aneuploidy rate? Fertil Steril 2013. [DOI: 10.1016/j.fertnstert.2013.07.314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
62
|
Littman E, Phan V, Harris D, Severino M, La A. Blastocysts formed on day 5 have more chance to be euploid. Fertil Steril 2013. [DOI: 10.1016/j.fertnstert.2013.07.272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
63
|
Ong J, Harris D, Jeffers G, Watson L, Ballantine L, Beresford M. THU0296 Matrix interference of IL-6, IL-17, IL-21 and TNF-alpha measurement in juvenile-onset systemic lupus erythematosus serum and plasma:. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
64
|
Karrar S, Shiwen X, Nikotorowicz-Buniak J, Abraham DJ, Denton C, Stratton R, Bayley R, Kite KA, Clay E, Smith JP, Kitas GD, Buckley C, Young SP, Ye L, Zhang L, Goodall J, Gaston H, Xu H, Lutalo PM, Zhao Y, Meng Choong L, Sangle S, Spencer J, D'Cruz D, Rysnik OJ, McHugh K, Bowness P, Rump-Goodrich L, Mattey D, Kehoe O, Middleton J, Cartwright A, Schmutz C, Askari A, Middleton J, Gardner DH, Jeffery LE, Raza K, Sansom DM, Clay E, Bayley R, Fitzpatrick M, Wallace G, Young S, Shaw J, Hatano H, Cauli A, Giles JL, McHugh K, Mathieu A, Bowness P, Kollnberger S, Webster S, Ellis L, O'Brien LM, Fitzmaurice TJ, Gaston H, Goodall J, Nazeer Moideen A, Evans L, Osgood L, Williams A, Jones S, Thomas C, O'Donnell V, Nowell M, Ouboussad L, Savic S, Dickie LJ, Hintze J, Wong CH, Cook GP, Buch M, Emery P, McDermott MF, Hardcastle SA, Gregson CL, Deere K, Davey Smith G, Dieppe P, Tobias JH, Dennison E, Edwards M, Bennett J, Coggon D, Palmer K, Cooper C, McWilliams D, Young A, Kiely PD, Walsh D, Taylor HJ, Harding I, Hutchinson J, Nelson I, Blom A, Tobias J, Clark E, Parker J, Bukhari M, McWilliams D, Jayakumar K, Young A, Kiely P, Walsh D, Diffin J, Lunt M, Marshall T, Chipping J, Symmons D, Verstappen S, Taylor HJ, Harding I, Hutchinson J, Nelson I, Tobias J, Clark E, Bluett J, Bowes J, Ho P, McHugh N, Buden D, Fitzgerald O, Barton A, Glossop JR, Nixon NB, Emes RD, Dawes PT, Farrell WE, Mattey DL, Scott IC, Steer S, Seegobin S, Hinks AM, Eyre S, Morgan A, Wilson AG, Hocking L, Wordsworth P, Barton A, Worthington J, Cope A, Lewis CM, Guerra S, Ahmed BA, Denton C, Abraham D, Fonseca C, Robinson J, Taylor J, Haroon Rashid L, Flynn E, Eyre S, Worthington J, Barton A, Isaacs J, Bowes J, Wilson AG, Barrett JH, Morgan A, Kingston B, Ahmed M, Kirwan JR, Marshall R, Chapman K, Pearson R, Heycock C, Kelly C, Rynne M, Saravanan V, Hamilton J, Saeed A, Coughlan R, Carey JJ, Farah Z, Matthews W, Bell C, Petford S, Tibbetts LM, Douglas KMJ, Holden W, Ledingham J, Fletcher M, Winfield R, Price Z, Mackay K, Dixon C, Oppong R, Jowett S, Nicholls E, Whitehurst D, Hill S, Hammond A, Hay E, Dziedzic K, Righetti C, Lebmeier M, Manning VL, Hurley M, Scott DL, Choy E, Bearne L, Nikiphorou E, Morris S, James D, Kiely P, Walsh D, Young A, Wong EC, Long J, Fletcher A, Fletcher M, Holmes S, Hockey P, Abbas M, Chattopadhyay C, Flint J, Gayed M, Schreiber K, Arthanari S, Nisar M, Khamashta M, Gordon C, Giles I, Robson J, Kiran A, Maskell J, Arden N, Hutchings A, Emin A, Culliford D, Dasgupta B, Hamilton W, Luqmani R, Jethwa H, Rowczenio D, Trojer H, Russell T, Loeffler J, Hawkins P, Lachmann H, Verma I, Syngle A, Krishan P, Garg N, Flint J, Gayed M, Schreiber K, Arthanari S, Nisar M, Khamashta M, Gordon C, Giles I, McGowan SP, Gerrard DT, Chinoy H, Ollier WE, Cooper RG, Lamb JA, Taborda L, Correia Azevedo P, Isenberg D, Leyland KM, Kiran A, Judge A, Hunter D, Hart D, Javaid MK, Arden N, Cooper C, Edwards MH, Litwic AE, Jameson KA, Deeg D, Cooper C, Dennison E, Edwards MH, Jameson KA, Cushnaghan J, Aihie Sayer A, Deeg D, Cooper C, Dennison E, Jagannath D, Parsons C, Cushnaghan J, Cooper C, Edwards MH, Dennison E, Stoppiello L, Mapp P, Ashraf S, Wilson D, Hill R, Scammell B, Walsh D, Wenham C, Shore P, Hodgson R, Grainger A, Aaron J, Hordon L, Conaghan P, Bar-Ziv Y, Beer Y, Ran Y, Benedict S, Halperin N, Drexler M, Mor A, Segal G, Lahad A, Haim A, Rath U, Morgensteren DM, Salai M, Elbaz A, Vasishta VG, Derrett-Smith E, Hoyles R, Khan K, Abraham DJ, Denton C, Ezeonyeji A, Takhar G, Denton C, Ong V, Loughrey L, Bissell LA, Hensor E, Abignano G, Redmond A, Buch M, Del Galdo F, Hall FC, Malaviya A, Nisar M, Baker S, Furlong A, Mitchell A, Godfrey AL, Ruddlesden M, Hadjinicolaou A, Hughes M, Moore T, O'Leary N, Tracey A, Ennis H, Dinsdale G, Roberts C, Herrick A, Denton CP, Guillevin L, Hunsche E, Rosenberg D, Schwierin B, Scott M, Krieg T, Anderson M, Hall FC, Herrick A, McHugh N, Matucci-Cerinic M, Alade R, Khan K, Xu S, Denton C, Ong V, Nihtyanova S, Ong V, Denton CP, Clark KE, Tam FWK, Unwin R, Khan K, Abraham DJ, Denton C, Stratton RJ, Nihtyanova S, Schreiber B, Ong V, Denton CP, Seng Edwin Lim C, Dasgupta B, Corsiero E, Sutcliffe N, Wardemann H, Pitzalis C, Bombardieri M, Tahir H, Donnelly S, Greenwood M, Smith TO, Easton V, Bacon H, Jerman E, Armon K, Poland F, Macgregor A, van der Heijde D, Sieper J, Elewaut D, Pangan AL, Nguyen D, Badenhorst C, Kirby S, White D, Harrison A, Garcia JA, Stebbings S, MacKay JW, Aboelmagd S, Gaffney K, van der Heijde D, Deodhar A, Braun J, Mack M, Hsu B, Gathany T, Han C, Inman RD, Cooper-Moss N, Packham J, Strauss V, Freeston JE, Coates L, Nam J, Moverley AR, Helliwell P, Hensor E, Wakefield R, Emery P, Conaghan P, Mease P, Fleischmann R, Wollenhaupt J, Deodhar A, Kielar D, Woltering F, Stach C, Hoepken B, Arledge T, van der Heijde D, Gladman D, Fleischmann R, Coteur G, Woltering F, Mease P, Kavanaugh A, Gladman D, van der Heijde D, Purcaru O, Mease P, McInnes I, Kavanaugh A, Gottlieb AB, Puig L, Rahman P, Ritchlin C, Li S, Wang Y, Mendelsohn A, Doyle M, Tillett W, Jadon D, Shaddick G, Cavill C, Robinson G, Sengupta R, Korendowych E, de Vries C, McHugh N, Thomas RC, Shuto T, Busquets-Perez N, Marzo-Ortega H, McGonagle D, Tillett W, Richards G, Cavill C, Sengupta R, Shuto T, Marzo-Ortega H, Thomas RC, Bingham S, Coates L, Emery P, John Hamlin P, Adshead R, Cambridge S, Donnelly S, Tahir H, Suppiah P, Cullinan M, Nolan A, Thompson WM, Stebbings S, Mathieson HR, Mackie SL, Bryer D, Buch M, Emery P, Marzo-Ortega H, Krutikov M, Gray L, Bruce E, Ho P, Marzo-Ortega H, Busquets-Perez N, Thomas RC, Gaffney K, Keat A, Innes W, Pandit R, Kay L, Lapshina S, Myasoutova L, Erdes S, Wallis D, Waldron N, McHugh N, Korendowych E, Thorne I, Harris C, Keat A, Garg N, Syngle A, Vohra K, Khinchi D, Verma I, Kaur L, Jones A, Harrison N, Harris D, Jones T, Rees J, Bennett A, Fazal S, Tugnet N, Barkham N, Basu N, McClean A, Harper L, Amft EN, Dhaun N, Luqmani RA, Little MA, Jayne DR, Flossmann O, McLaren J, Kumar V, Reid DM, Macfarlane GJ, Jones G, Yates M, Watts RA, Igali L, Mukhtyar C, Macgregor A, Robson J, Doll H, Yew S, Flossmann O, Suppiah R, Harper L, Hoglund P, Jayne D, Mukhtyar C, Westman K, Luqmani R, Win Maw W, Patil P, Williams M, Adizie T, Christidis D, Borg F, Dasgupta B, Robertson A, Croft AP, Smith S, Carr S, Youssouf S, Salama A, Pusey C, Harper L, Morgan M. Basic Science * 208. Stem Cell Factor Expression is Increased in the Skin of Patients with Systemic Sclerosis and Promotes Proliferation and Migration of Fibroblasts in vitro. Rheumatology (Oxford) 2013. [DOI: 10.1093/rheumatology/ket195] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
|
65
|
Bennett AN, Green AD, Rees J, Jones T, Harris D, Etherington J. The safety and efficacy, and recommendations for the use of biologic drugs in the UK military rheumatology population. J ROY ARMY MED CORPS 2013; 159:8-14. [DOI: 10.1136/jramc-2013-000001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
66
|
Harris D, Huang B, Oback B. 89 INHIBITION OF MAPKK AND GSK3 SIGNALLING PROMOTES DEVELOPMENT AND EPIBLAST-SPECIFIC EXPRESSION OF PLURIPOTENCY MARKERS IN BOVINE BLASTOCYSTS. Reprod Fertil Dev 2013. [DOI: 10.1071/rdv25n1ab89] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
During blastocyst development, the inner cell mass segregates into the epiblast and the hypoblast. These 2 tissues form morphologically and molecularly distinct cell populations that subsequently develop into the embryo proper and some extraembryonic components, respectively. In mouse, isolated epiblast cells can be directly converted into pluripotent embryonic stem cells, capable of differentiating into all cell types of an adult animal. Epiblast pluripotency is promoted by pharmacological inhibition of mitogen-activated protein kinase kinase (Mapkk). This shields epiblast cells from secreted fibroblast growth factor (Fgf), which would otherwise instruct them to exit pluripotency and differentiate into extraembryonic lineages. Indirect stimulation of the Wnt pathway by inhibiting glycogen synthase kinase 3 (GSK3) further antagonises inductive Fgf/Mapkk signalling. Thus the double inhibition (2i) of Mapkk and Gsk3 effectively promotes pluripotency (Q. L. Ying et al. 2008 Nature 453, 519–523; J. Nichols et al. 2009 Development 136, 3215–3222). We investigated the effect of 2i culture on bovine blastocysts. The IVF embryos were cultured in the presence of dimethyl sulfoxide or inhibitors of MAPKK (0.4 µM PD0325901) and GSK3 (3 µM CHIR99021) from the zygote (Day 1) stage onward. Compared to vehicle controls, 2i increased the abundance of cumulus cells in bovine IVF cultures, compromising blastocyst formation in cumulus-intact (248/823 = 30% v. 211/824 = 26%, respectively, n = 10; P < 0.05) but not cumulus-free cultures (546/1653 = 33% v. 572/1674 = 34%, respectively, n = 15; P = 0.51). In all subsequent experiments, we therefore cultured cumulus-free zygotes in 2i v. dimethyl sulfoxide until the blastocyst stage. This treatment increased the proportion of hatching (19/433 = 4% v. 7/416 = 2%, respectively, n = 10; P < 0.05) at the expense of early blastocysts (70/433 = 16% v. 93/416 = 22%, respectively, n = 11; P < 0.05). Differential staining of expanded IETS grade 1 and 2 blastocysts showed that 2i culture increased putative inner cell mass, trophectoderm, and total cell nuclei numbers by about 30% compared with controls (57 v. 43, 89 v. 69, and 146 v. 112, respectively; P < 0.01). Accelerated development and increased cell numbers were accompanied by gene expression changes in grade 1 and 2 blastocysts. Under 2i conditions, mRNA abundance of putative epiblast markers NANOG and SOX2 was >3-fold increased (P < 0.0001 and P < 0.01, respectively), and the putative hypoblast marker GATA4 was 2-fold reduced (P < 0.05). Other lineage-related markers (POU5F1, KLF4, DPPA3, and CDX2) showed no significant changes. Using microsurgical blastocyst dissection, we found that the increase in NANOG and SOX2 levels was specific to the inner cell mass-containing portion (7-fold for NANOG and 3-fold for SOX2; P < 0.00005 and P < 0.05, respectively) and not due to ectopic expression in the trophoblast-containing part, which showed similarly low expression levels for both genes. In summary, 2i treatment primed bovine blastocysts for pluripotency in the epiblast.
Supported by MSI C10X1002.
Collapse
|
67
|
McKeage M, Kotasek D, Millward M, Markman B, Jameson M, Hidalgo M, Harris D, Stagg R, Dupont J, Hughes B. 598 A Phase 1b Study of Demcizumab Plus Pemetrexed and Carboplatin in Patients with 1st Line Non-Small Cell Lung Cancer (NSCLC). Eur J Cancer 2012. [DOI: 10.1016/s0959-8049(12)72395-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
68
|
Little F, Brown L, Grotowski M, Harris D. Nourishing networks: an interprofessional learning model and its application to the Australian rural health workforce. Rural Remote Health 2012; 12:2022. [PMID: 23121159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023] Open
Abstract
CONTEXT Access to continuing professional development for rural health clinicians requires strategies to overcome barriers associated with finances, travel and a lack of resources. Approaches to providing professional development need to transcend conventional educational methods and consider interprofessional educational opportunities to meet the diverse needs of the rural health workforce. Rural clinicians often work in professional isolation and frequently work collaboratively with clinicians from a range of other health disciplines. Interprofessional learning and practice is therefore important in a rural areas as clinicians working in these settings are often more reliant on each other and require an understanding of other's roles to provide effective health care. In addition, specialist services are limited in rural areas, with health professionals increasingly required to perform extended roles at an advanced-practice level. ISSUES A model for interprofessional learning has been developed to attempt to address the barriers related to the delivery of interprofessional education in the rural health setting in Australia. This model demonstrates a flexible approach to interprofessional learning which meets different educational needs across a number of health disciplines, and is tailored to varying levels of expertise. It incorporates three learning approaches: traditional learning, flexible learning and advanced practice. Each of these components of the model are described and the Nourishing Networks program is provided as an example of the application of the model in a rural setting, utilising 'eating disorders' as the educational topic. LESSONS LEARNED Interprofessional learning can be delivered effectively in a rural setting by utilising technology to help bridge the isolation experienced in rural practice. Challenges in delivering the interprofessional learning program included: engaging rural general practitioners, utilising technology and maintaining participant engagement. The use of technology is essential to access a broad group of rural clinicians however, there are limitations in its use that must be acknowledged. The pilot of the Stepped Interprofessional Rural Learning Model and its application to eating disorders has scope for use in delivering education for other health topics.
Collapse
|
69
|
Phan KV, Littman E, Harris D, Lopez C, La A. Correlation between embryo morphology and development and chromosomal complement. Fertil Steril 2012. [DOI: 10.1016/j.fertnstert.2012.07.1006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
70
|
Littman E, Phan KV, Harris D, Lopez C, La A. Age related correction of mosaicism in day 5 and day 6 blastocysts reanalyzed for aneuploidy. Fertil Steril 2012. [DOI: 10.1016/j.fertnstert.2012.07.1028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
71
|
Zaghloul M, Ahmed S, Eldebaway E, Mousa A, Amin A, Elkhateeb N, Sabry M, Ogiwara H, Morota N, Sufit A, Donson A, Birks D, Patel P, Foreman N, Handler M, Massimino M, Biassoni V, Gandola L, Schiavello E, Pecori E, Potepan P, Bach F, Janssens GO, Jansen MH, Lauwers SJ, Nowak PJ, Oldenburger FR, Bouffet E, Saran F, van Ulzen KK, van Lindert EJ, Schieving JH, Boterberg T, Kaspers GJ, Span PN, Kaanders JH, Gidding CE, Hargrave D, Bailey S, Howman A, Pizer B, Harris D, Jones D, Kearns P, Picton S, Saran F, Wheatley K, Gibson M, Glaser A, Connolly D, Hargrave D, Kawamura A, Nagashima T, Yamamoto K, Sakata J, Lober R, Freret M, Fisher P, Edwards M, Yeom K, Monje M, Jansen M, Aliaga ES, Van Der Hoeven E, Van Vuurden D, Heymans M, Gidding C, De Bont E, Reddingius R, Peeters-Scholte C, van Meeteren AS, Gooskens R, Granzen B, Paardekoper G, Janssens G, Noske D, Barkhof F, Vandertop WP, Kaspers G, Saratsis A, Yadavilli S, Nazarian J, Monje M, Freret M, Mitra S, Mallick S, Kim J, Beachy P, Nobre L, Vasconcelos F, Lima F, Mattos D, Kuiven N, Lima G, Silveira J, Sevilha M, Lima MA, Ferman S, Leblond P, Lansiaux A, Rialland X, Gentet JC, Geoerger B, Frappaz D, Aerts I, Bernier-Chastagner V, Shah R, Zaky W, Grimm J, Bluml S, Wong K, Dhall G, Caretti V, Schellen P, Lagerweij T, Bugiani M, Navis A, Wesseling P, Vandertop WP, Noske DP, Kaspers G, Wurdinger T, Lee H, Ziegler D, Schroeder K, Huang E, Berlow N, Patel R, Becher O, Taylor I, Mao XG, Hutt M, Weingart M, Kahlert U, Maciacyk J, Nikkhah G, Eberhart C, Raabe E, Barton K, Misuraca K, Misuraca K, Becher O, Zhou Z, Rotman L, Ho S, Souweidane M, Hutt M, Lim KJ, Warren K, Chang H, Eberhart C, Raabe E, Lightner D, Haque S, Souweidane M, Khakoo Y, Dunkel I, Gilheeney S, Kramer K, Lyden D, Wolden S, Greenfield J, De Braganca K, Ting-Rong H, Muh-Li L, Kai-Ping C, Tai-Tong W, Hsin-Hung C, Kebudi R, Cakir FB, Agaoglu FY, Gorgun O, Dizdar Y, Ayan I, Darendeliler E, Zapotocky M, Churackova M, Malinova B, Kodet R, Kyncl M, Tichy M, Stary J, Sumerauer D, Minturn J, Shu HK, Fisher M, Patti R, Janss A, Allen J, Phillips P, Belasco J, Taylor K, Baudis M, von Beuren A, Fouladi M, Jones C. DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG). Neuro Oncol 2012. [DOI: 10.1093/neuonc/nos098] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
72
|
Al-Mufti F, Gupta N, Coyle P, Harris D, Medin K, Kim B. A Tertiary Care Center's Experience with Central Nervous System Vasculitis (CNSV) (P07.016). Neurology 2012. [DOI: 10.1212/wnl.78.1_meetingabstracts.p07.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
73
|
Nieves C, Eppig J, Libon D, Harris D, Feldman S, Paolone M, Rojas L, Deboo A, Heiman-Patterson T. Forced Vital Capacity, Bulbar Onset, and Neuropsychological Impairment in Amyotrophic Lateral Sclerosis (ALS) (P04.231). Neurology 2012. [DOI: 10.1212/wnl.78.1_meetingabstracts.p04.231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
74
|
Touquet R, Harris D. Alcohol Misuse Y91 Coding in ICD-11: Rational Terminology and Logical Coding Specifically to Encourage Early Identification and Advice. Alcohol Alcohol 2012; 47:213-5. [DOI: 10.1093/alcalc/ags012] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
75
|
Resnicow K, Mcmaster F, Woolford S, Slora E, Bocian A, Harris D, Drehmer J, Wasserman R, Schwartz R, Myers E, Foster J, Snetselaar L, Hollinger D, Smith K. Study design and baseline description of the BMI2 trial: reducing paediatric obesity in primary care practices. Pediatr Obes 2012; 7:3-15. [PMID: 22434735 PMCID: PMC5427511 DOI: 10.1111/j.2047-6310.2011.00001.x] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/28/2011] [Revised: 08/01/2011] [Accepted: 08/29/2011] [Indexed: 02/06/2023]
Abstract
OBJECTIVES This study will test the efficacy of motivational interviewing (MI) conducted by primary care providers and dieticians among children ages 2-8 years old with a body mass index (BMI) ≥ 85th and ≤ 97th percentile. METHODS Forty-two practices from the American Academy of Pediatrics, Pediatric Research in Office Settings Network were assigned to one of three groups. Group 1 (usual care) measures BMI percentile at baseline, and at 1- and 2-year follow-ups and receives standard health education materials. Group 2 providers deliver three proactive MI counselling sessions with a parent of the index child in Year 1 and one additional 'booster' visit in Year 2. Group 3 adds six MI counselling sessions from a trained dietician. The primary outcome is the child's BMI percentile at 2-year follow-up. Secondary outcomes include parent report of the child's screen time, physical activity, intake of fruits and vegetables, and sugar-sweetened beverages. RESULTS We enrolled 633 eligible children whose mean BMI percentile was 92.0 and mean age of 5.1. The cohort was 57% female. Almost 70% of parents reported a household income of ≥ $40,000 per year, and 39% had at least a college education. The cohort was 63% white, 23% Hispanic, 7% black and 7% Asian. Parent self-reported confidence that their child will achieve a healthy weight was on average an 8 (out of 10). CONCLUSION To date, several aspects of the study can inform similar efforts including our ability to use volunteer clinicians to recruit participants and their willingness to dedicate their time, without pay, to receive training in MI.
Collapse
|
76
|
Szram J, Schofield SJ, Woods APM, Crisp N, Harris D, Cullinan P. S3 Work performance and airflow obstruction in a general UK population of older workers. Thorax 2011. [DOI: 10.1136/thoraxjnl-2011-201054b.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
77
|
Gill JL, James VM, Carta E, Harris D, Topf M, Scholes SFE, Hateley G, Harvey RJ. Identification of congenital muscular dystonia 2 associated with an inherited GlyT2 defect in Belgian Blue cattle from the United Kingdom. Anim Genet 2011; 43:267-70. [PMID: 22486497 DOI: 10.1111/j.1365-2052.2011.02255.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Two newborn Belgian Blue calves from a farm in the United Kingdom exhibited lateral recumbency, low head carriage and transient muscle spasms following tactile or auditory stimulation. DNA sequence analysis indicated that both calves were homozygous for the recessive congenital muscular dystonia type 2 (CMD2) mutation (c.809T>C, p.Leu270Pro) in SLC6A5, encoding the neuronal glycine transporter GlyT2. Further testing of animals from the index farm and a sample of Belgian Blue sires revealed an unexpectedly high frequency of CMD2 carriers. This implies that linked quantitative trait loci may be influencing the prevalence of CMD2 in the estimated 55,000 Belgian Blue cattle in the United Kingdom. We have therefore developed new inexpensive tests for the CMD2 allele that can be used to confirm diagnosis, identify carriers and guide future breeding strategy, thus avoiding animal distress/premature death and minimizing the future economic impact of this disorder.
Collapse
|
78
|
Adamson P, Andreopoulos C, Auty DJ, Ayres DS, Backhouse C, Barr G, Bishai M, Blake A, Bock GJ, Boehnlein DJ, Bogert D, Cavanaugh S, Cherdack D, Childress S, Choudhary BC, Coelho JAB, Coleman SJ, Corwin L, Cronin-Hennessy D, Danko IZ, de Jong JK, Devenish NE, Diwan MV, Dorman M, Escobar CO, Evans JJ, Falk E, Feldman GJ, Frohne MV, Gallagher HR, Gomes RA, Goodman MC, Gouffon P, Graf N, Gran R, Grant N, Grzelak K, Habig A, Harris D, Hartnell J, Hatcher R, Himmel A, Holin A, Howcroft C, Huang X, Hylen J, Ilic J, Irwin GM, Isvan Z, Jaffe DE, James C, Jensen D, Kafka T, Kasahara SMS, Koizumi G, Kopp S, Kordosky M, Kreymer A, Lang K, Lefeuvre G, Ling J, Litchfield PJ, Loiacono L, Lucas P, Mann WA, Marshak ML, Mayer N, McGowan AM, Mehdiyev R, Meier JR, Messier MD, Miller WH, Mishra SR, Mitchell J, Moore CD, Morfín J, Mualem L, Mufson S, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nicholls TC, Nowak JA, Ochoa-Ricoux JP, Oliver WP, Orchanian M, Ospanov R, Paley J, Patterson RB, Pawloski G, Pearce GF, Petyt DA, Phan-Budd S, Plunkett RK, Qiu X, Ratchford J, Raufer TM, Rebel B, Rodrigues PA, Rosenfeld C, Rubin HA, Sanchez MC, Schneps J, Schreiner P, Shanahan P, Sousa A, Stamoulis P, Strait M, Tagg N, Talaga RL, Tetteh-Lartey E, Thomas J, Thomson MA, Tinti G, Toner R, Tzanakos G, Urheim J, Vahle P, Viren B, Weber A, Webb RC, White C, Whitehead L, Wojcicki SG, Yang T, Zwaska R. First direct observation of muon antineutrino disappearance. PHYSICAL REVIEW LETTERS 2011; 107:021801. [PMID: 21797594 DOI: 10.1103/physrevlett.107.021801] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/02/2011] [Indexed: 05/31/2023]
Abstract
This Letter reports the first direct observation of muon antineutrino disappearance. The MINOS experiment has taken data with an accelerator beam optimized for ν(μ) production, accumulating an exposure of 1.71 × 10²⁰ protons on target. In the Far Detector, 97 charged current ν(μ) events are observed. The no-oscillation hypothesis predicts 156 events and is excluded at 6.3σ. The best fit to oscillation yields |Δm²| = [3.36(-0.40)(+0.46)(stat) ± 0.06(syst)] × 10⁻³ eV², sin²(2θ) = 0.86(-0.12)(+0.11)(stat) ± 0.01(syst). The MINOS ν(μ) and ν(μ) measurements are consistent at the 2.0% confidence level, assuming identical underlying oscillation parameters.
Collapse
|
79
|
Adamson P, Auty DJ, Ayres DS, Backhouse C, Barr G, Bishai M, Blake A, Bock GJ, Boehnlein DJ, Bogert D, Cavanaugh S, Cherdack D, Childress S, Coelho JAB, Coleman SJ, Corwin L, Cronin-Hennessy D, Danko IZ, de Jong JK, Devenish NE, Diwan MV, Dorman M, Escobar CO, Evans JJ, Falk E, Feldman GJ, Frohne MV, Gallagher HR, Gomes RA, Goodman MC, Gouffon P, Graf N, Gran R, Grant N, Grzelak K, Habig A, Harris D, Hartnell J, Hatcher R, Himmel A, Holin A, Huang X, Hylen J, Ilic J, Irwin GM, Isvan Z, Jaffe DE, James C, Jensen D, Kafka T, Kasahara SMS, Koizumi G, Kopp S, Kordosky M, Kreymer A, Lang K, Lefeuvre G, Ling J, Litchfield PJ, Loiacono L, Lucas P, Mann WA, Marshak ML, Mayer N, McGowan AM, Mehdiyev R, Meier JR, Messier MD, Miller WH, Mishra SR, Mitchell J, Moore CD, Morfín J, Mualem L, Mufson S, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nicholls TC, Nowak JA, Oliver WP, Orchanian M, Paley J, Patterson RB, Pawloski G, Pearce GF, Petyt DA, Phan-Budd S, Pittam R, Plunkett RK, Qiu X, Ratchford J, Raufer TM, Rebel B, Rodrigues PA, Rosenfeld C, Rubin HA, Sanchez MC, Schneps J, Schreiner P, Sharma R, Shanahan P, Sousa A, Stamoulis P, Strait M, Tagg N, Talaga RL, Tetteh-Lartey E, Thomas J, Thomson MA, Tinti G, Toner R, Torretta D, Tzanakos G, Urheim J, Vahle P, Viren B, Walding JJ, Weber A, Webb RC, White C, Whitehead L, Wojcicki SG, Zwaska R. Active to sterile neutrino mixing limits from neutral-current interactions in MINOS. PHYSICAL REVIEW LETTERS 2011; 107:011802. [PMID: 21797535 DOI: 10.1103/physrevlett.107.011802] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/19/2011] [Indexed: 05/31/2023]
Abstract
Results are reported from a search for active to sterile neutrino oscillations in the MINOS long-baseline experiment, based on the observation of neutral-current neutrino interactions, from an exposure to the NuMI neutrino beam of 7.07×10(20) protons on target. A total of 802 neutral-current event candidates is observed in the Far Detector, compared to an expected number of 754 ± 28(stat) ± 37(syst) for oscillations among three active flavors. The fraction f(s) of disappearing ν(μ) that may transition to ν(s) is found to be less than 22% at the 90% C.L.
Collapse
|
80
|
Adamson P, Andreopoulos C, Armstrong R, Auty DJ, Ayres DS, Backhouse C, Barr G, Bishai M, Blake A, Bock GJ, Boehnlein DJ, Bogert D, Cavanaugh S, Cherdack D, Childress S, Choudhary BC, Coelho JAB, Coleman SJ, Corwin L, Cronin-Hennessy D, Danko IZ, de Jong JK, Devenish NE, Diwan MV, Dorman M, Escobar CO, Evans JJ, Falk E, Feldman GJ, Frohne MV, Gallagher HR, Gomes RA, Goodman MC, Gouffon P, Graf N, Gran R, Grant N, Grzelak K, Habig A, Harris D, Hartnell J, Hatcher R, Himmel A, Holin A, Huang X, Hylen J, Ilic J, Irwin GM, Isvan Z, Jaffe DE, James C, Jensen D, Kafka T, Kasahara SMS, Koizumi G, Kopp S, Kordosky M, Kreymer A, Lang K, Lefeuvre G, Ling J, Litchfield PJ, Litchfield RP, Loiacono L, Lucas P, Mann WA, Marshak ML, Mayer N, McGowan AM, Mehdiyev R, Meier JR, Messier MD, Michael DG, Miller WH, Mishra SR, Mitchell J, Moore CD, Morfín J, Mualem L, Mufson S, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nowak JA, Oliver WP, Orchanian M, Ospanov R, Paley J, Patterson RB, Pawloski G, Pearce GF, Petyt DA, Phan-Budd S, Plunkett RK, Qiu X, Ratchford J, Raufer TM, Rebel B, Rodrigues PA, Rosenfeld C, Rubin HA, Sanchez MC, Schneps J, Schreiner P, Shanahan P, Smith C, Sousa A, Stamoulis P, Strait M, Tagg N, Talaga RL, Thomas J, Thomson MA, Tinti G, Toner R, Tzanakos G, Urheim J, Vahle P, Viren B, Weber A, Webb RC, White C, Whitehead L, Wojcicki SG, Yang T, Zwaska R. Measurement of the neutrino mass splitting and flavor mixing by MINOS. PHYSICAL REVIEW LETTERS 2011; 106:181801. [PMID: 21635083 DOI: 10.1103/physrevlett.106.181801] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/02/2011] [Indexed: 05/30/2023]
Abstract
Measurements of neutrino oscillations using the disappearance of muon neutrinos from the Fermilab NuMI neutrino beam as observed by the two MINOS detectors are reported. New analysis methods have been applied to an enlarged data sample from an exposure of 7.25×10(20) protons on target. A fit to neutrino oscillations yields values of |Δm(2)|=(2.32(-0.08)(+0.12))×10(-3) eV(2) for the atmospheric mass splitting and sin(2)(2θ)>0.90 (90% C.L.) for the mixing angle. Pure neutrino decay and quantum decoherence hypotheses are excluded at 7 and 9 standard deviations, respectively.
Collapse
|
81
|
Pagliaro LC, Munsell M, Harris D, Carolla RL, Siefker-Radtke AO. Gemcitabine, paclitaxel, and doxorubicin for patients (pts) with urothelial carcinoma (UC) and renal insufficiency: Preliminary results of a multicenter phase II study. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.7_suppl.246] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
246 Background: The role of cisplatin-based chemotherapy for the treatment of locally advanced or metastatic UC is well established. Pts with impaired renal function cannot receive cisplatin, however, and substitution with carboplatin yielded inferior results. We initiated a phase II study to assess the efficacy of gemcitabine, paclitaxel, and doxorubicin (GTA) treatment for UC in pts with renal insufficiency. Methods: Eligible pts had metastatic or unresectable UC of bladder, urethra, or upper tract, no prior chemotherapy, glomerular filtration rate < 60 ml/min, ECOG performance status ≤ 2, left ventricular ejection fraction > 40%, and adequate hematopoietic and hepatic function. Pts were excluded if they had brain metastasis, peripheral neuropathy ≥ grade 2, significant heart disease within 6 months of enrollment, or required hemodialysis. Outpatient treatment consisted of 900 mg/m2 gemcitabine, 135 mg/m2 paclitaxel, and 40 mg/m2 doxorubicin on day 1 every 2 weeks. Pegfilgrastim 6 mg sc was given immediately after GTA on day 1, or on day 2 if requested by the pt. Tumor evaluation was repeated every 3 cycles (6 weeks); treatment duration was limited to 9 cycles. A Simon 2-stage design was chosen to detect a target overall response rate of 40% and to reject a response rate of 25% or less. Results: Twenty-five pts enrolled and 21 could be assessed for response. Median (range) age was 72.8 years (53.4, 89.3) and 8 pts (32.0%) were female. RECIST responses occurred in 12 pts (4 complete; 8 partial), for an overall response rate of 57.1% (95% CI 34.0-78.2). Notable grade 3 and 4 toxicities were anemia (9 pts), thrombocytopenia (3 pts), neutropenia (2 pts), dyspnea (1 pt), mucositis (1 pt), and sepsis (1 pt). No adverse events were attributed to same-day pegfilgrastim and there were no treatment-related deaths. Eleven pts (44.0%) died of progressive disease; the median (range) follow-up time for 14 surviving pts was 5.5 months (2.3, 17.5). Conclusions: GTA has been well-tolerated in the setting of renal insufficiency, with an observed response rate in advanced UC exceeding the targeted response. The study will continue to a maximum of 72 pts. [Table: see text]
Collapse
|
82
|
Harris D, Li WC. An extension of the Human Factors Analysis and Classification System for use in open systems. THEORETICAL ISSUES IN ERGONOMICS SCIENCE 2011. [DOI: 10.1080/14639220903536559] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
83
|
Adamson P, Andreopoulos C, Auty DJ, Ayres DS, Backhouse C, Barr G, Barrett WL, Bhattarai P, Bishai M, Blake A, Bock GJ, Boehnlein DJ, Bogert D, Budd S, Cavanaugh S, Cherdack D, Childress S, Choudhary BC, Coelho JAB, Coleman SJ, Corwin L, Cronin-Hennessy D, Damiani D, Danko IZ, de Jong JK, Devenish NE, Diwan MV, Dorman M, Escobar CO, Evans JJ, Falk E, Feldman GJ, Fields TH, Frohne MV, Gallagher HR, Gomes RA, Goodman MC, Gouffon P, Graf N, Gran R, Grant N, Grzelak K, Habig A, Harris D, Harris PG, Hartnell J, Hatcher R, Himmel A, Holin A, Huang X, Hylen J, Ilic J, Irwin GM, Isvan Z, Jaffe DE, James C, Jensen D, Kafka T, Kasahara SMS, Koizumi G, Kopp S, Kordosky M, Krahn Z, Kreymer A, Lang K, Lefeuvre G, Ling J, Litchfield PJ, Loiacono L, Lucas P, Mann WA, Marshak ML, Mayer N, McGowan AM, Mehdiyev R, Meier JR, Messier MD, Michael DG, Miller WH, Mishra SR, Mitchell J, Moore CD, Morfín J, Mualem L, Mufson S, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nowak JA, Oliver WP, Orchanian M, Paley J, Patterson RB, Pawloski G, Pearce GF, Pittam R, Plunkett RK, Qiu X, Ratchford J, Raufer TM, Rebel B, Reichenbacher J, Rodrigues PA, Rosenfeld C, Rubin HA, Ryabov VA, Sanchez MC, Saoulidou N, Schneps J, Schreiner P, Shanahan P, Sousa A, Strait M, Tagg N, Talaga RL, Thomas J, Thomson MA, Tinti G, Toner R, Tzanakos G, Urheim J, Vahle P, Viren B, Weber A, Webb RC, White C, Whitehead L, Wojcicki SG, Wright DM, Yang T, Zwaska R. Measurement of the underground atmospheric muon charge ratio using the MINOS Near Detector. Int J Clin Exp Med 2011. [DOI: 10.1103/physrevd.83.032011] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
84
|
Chittal R, Harris D, Patel A, Goodyear S, Parkianathan V. An interesting rare case of double volvulus. BMJ Case Rep 2011; 2011:2011/feb21_2/bcr1020103464. [PMID: 22707549 DOI: 10.1136/bcr.10.2010.3464] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
A 71-year-old female presented with recurrent sigmoid volvulus. In the current admission, her symptoms were not settling on conservative measures and subsequently went on to have laparotomy. During laparotomy, along with the sigmoid volvulus, there was associated gallbladder torsion. About 500 cases of gallbladder volvulus have been published in literature, however, in our literature search, the authors did not find any similar published case presenting with volvulus involving the gallbladder and the sigmoid colon at the same time. This patient went onto have cholecystectomy and sigmoid colectomy and had a good postoperative recovery and was discharged on the tenth postoperative day. At 6-week postoperative follow-up, she was doing well with no specific concerns.
Collapse
|
85
|
Scholefield JH, Harris D, Radcliffe A. Guidelines for management of anal intraepithelial neoplasia. Colorectal Dis 2011; 13 Suppl 1:3-10. [PMID: 21251167 DOI: 10.1111/j.1463-1318.2010.02494.x] [Citation(s) in RCA: 63] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
86
|
Barton M, Harris D. Tricyclic antidepressant overdose: an unusual method of administration. CASE REPORTS 2010. [DOI: 10.1136/bcr.04.2010.2914] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
87
|
Adamson P, Auty DJ, Ayres DS, Backhouse C, Barr G, Barrett WL, Bishai M, Blake A, Bock GJ, Boehnlein DJ, Bogert D, Bower C, Budd S, Cavanaugh S, Cherdack D, Childress S, Choudhary BC, Coelho JAB, Cobb JH, Coleman SJ, Corwin L, Cravens JP, Cronin-Hennessy D, Danko IZ, de Jong JK, Devenish NE, Diwan MV, Dorman M, Escobar CO, Evans JJ, Falk E, Feldman GJ, Frohne MV, Gallagher HR, Gomes RA, Goodman MC, Gouffon P, Gran R, Grant N, Grzelak K, Habig A, Harris D, Harris PG, Hartnell J, Hatcher R, Himmel A, Holin A, Huang X, Hylen J, Ilic J, Irwin GM, Isvan Z, Jaffe DE, James C, Jensen D, Kafka T, Kasahara SMS, Koizumi G, Kopp S, Kordosky M, Krahn Z, Kreymer A, Lang K, Lefeuvre G, Ling J, Litchfield PJ, Loiacono L, Lucas P, Mann WA, Marshak ML, Mayer N, McGowan AM, Mehdiyev R, Meier JR, Messier MD, Michael DG, Miller JL, Miller WH, Mishra SR, Mitchell J, Moore CD, Mualem L, Mufson S, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Oliver WP, Orchanian M, Paley J, Patterson RB, Patzak T, Pawloski G, Pearce GF, Pittam R, Plunkett RK, Ratchford J, Raufer TM, Rebel B, Rodrigues PA, Rosenfeld C, Rubin HA, Ryabov VA, Sanchez MC, Saoulidou N, Schneps J, Schreiner P, Semenov VK, Shanahan P, Smart W, Sousa A, Strait M, Tagg N, Talaga RL, Thomas J, Thomson MA, Tinti G, Toner R, Tzanakos G, Urheim J, Vahle P, Viren B, Weber A, Webb RC, White C, Whitehead L, Wojcicki SG, Wright DM, Yang T, Zois M, Zwaska R. Search for Lorentz invariance and CPT violation with the MINOS far detector. PHYSICAL REVIEW LETTERS 2010; 105:151601. [PMID: 21230890 DOI: 10.1103/physrevlett.105.151601] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/18/2010] [Indexed: 05/30/2023]
Abstract
We searched for a sidereal modulation in the MINOS far detector neutrino rate. Such a signal would be a consequence of Lorentz and CPT violation as described by the standard-model extension framework. It also would be the first detection of a perturbative effect to conventional neutrino mass oscillations. We found no evidence for this sidereal signature, and the upper limits placed on the magnitudes of the Lorentz and CPT violating coefficients describing the theory are an improvement by factors of 20-510 over the current best limits found by using the MINOS near detector.
Collapse
|
88
|
Harris D. Caecal perforation following apparently minor abdominal blunt trauma. Arch Emerg Med 2010; 27:707. [DOI: 10.1136/emj.2008.069112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
89
|
Thorn RG, Reddy CA, Harris D, Paul EA. Isolation of saprophytic basidiomycetes from soil. Appl Environ Microbiol 2010; 62:4288-92. [PMID: 16535455 PMCID: PMC1388993 DOI: 10.1128/aem.62.11.4288-4292.1996] [Citation(s) in RCA: 91] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
A method with the combined advantages of soil particle washing, selective inhibitors, and an indicator substrate was developed to isolate saprophytic basidiomycetes from soil. Organic particles were washed from soil and plated on a medium containing lignin, guaiacol, and benomyl, which reduced mold growth and allowed detection of basidiomycetes producing laccase or peroxidase. The 64 soil samples yielded 67 basidiomycete isolates, representing 51 groups on the basis of morphology and physiology. This method should facilitate investigations into the biodiversity of soil basidiomycetes and yield organisms that are useful in bioremediation of soils contaminated with pesticides or other recalcitrant aromatic compounds.
Collapse
|
90
|
Barua J, Campbell I I, Cole O, Harris D, Kaisary A, Larner T, Miller P, Nigam R, Mumtaz F, Thilagarajah R, Thompson A, Brown S. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up. BJU Int 2010; 104:1794; author eply 1794-5. [PMID: 20053194 DOI: 10.1111/j.1464-410x.2009.09065_1.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
91
|
Adamson P, Andreopoulos C, Arms KE, Armstrong R, Auty DJ, Ayres DS, Backhouse C, Barnes PD, Barr G, Barrett WL, Becker BR, Belias A, Bernstein RH, Betancourt M, Bhattacharya D, Bishai M, Blake A, Bock GJ, Boehm J, Boehnlein DJ, Bogert D, Bower C, Cavanaugh S, Chapman JD, Cherdack D, Childress S, Choudhary BC, Cobb JH, Coelho JAB, Coleman SJ, Cronin-Hennessy D, Culling AJ, Danko IZ, de Jong JK, Devenish NE, Diwan MV, Dorman M, Erwin AR, Escobar CO, Evans JJ, Falk E, Feldman GJ, Frohne MV, Gallagher HR, Godley A, Goodman MC, Gouffon P, Gran R, Grashorn EW, Grzelak K, Habig A, Harris D, Harris PG, Hartnell J, Hatcher R, Heller K, Himmel A, Holin A, Howcroft C, Huang X, Hylen J, Irwin GM, Isvan Z, Jaffe DE, James C, Jensen D, Kafka T, Kasahara SMS, Koizumi G, Kopp S, Kordosky M, Koskinen DJ, Krahn Z, Kreymer A, Lang K, Ling J, Litchfield PJ, Litchfield RP, Loiacono L, Lucas P, Ma J, Mann WA, Marshak ML, Marshall JS, Mayer N, McGowan AM, Mehdiyev R, Meier JR, Messier MD, Metelko CJ, Michael DG, Miller WH, Mishra SR, Mitchell J, Moore CD, Morfín J, Mualem L, Mufson S, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nicholls TC, Ochoa-Ricoux JP, Oliver WP, Ospanov R, Paley J, Para A, Patterson RB, Patzak T, Pavlović Z, Pawloski G, Pearce GF, Petyt DA, Pittam R, Plunkett RK, Rahaman A, Rameika RA, Raufer TM, Rebel B, Reichenbacher J, Rodrigues PA, Rosenfeld C, Rubin HA, Ryabov VA, Sanchez MC, Saoulidou N, Schneps J, Schreiner P, Shanahan P, Smart W, Smith C, Sousa A, Speakman B, Stamoulis P, Strait M, Tagg N, Talaga RL, Thomas J, Thomson MA, Thron JL, Tinti G, Toner R, Tsarev VA, Tzanakos G, Urheim J, Vahle P, Viren B, Ward DR, Watabe M, Weber A, Webb RC, West N, White C, Whitehead L, Wojcicki SG, Wright DM, Yang T, Zhang K, Zheng H, Zois M, Zwaska R. Search for muon-neutrino to electron-neutrino transitions in MINOS. PHYSICAL REVIEW LETTERS 2009; 103:261802. [PMID: 20366304 DOI: 10.1103/physrevlett.103.261802] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/27/2009] [Indexed: 05/29/2023]
Abstract
This Letter reports on a search for nu(mu) --> nu(e) transitions by the MINOS experiment based on a 3.14x10(20) protons-on-target exposure in the Fermilab NuMI beam. We observe 35 events in the Far Detector with a background of 27+/-5(stat)+/-2(syst) events predicted by the measurements in the Near Detector. If interpreted in terms of nu(mu) --> nu(e) oscillations, this 1.5sigma excess of events is consistent with sin2(2theta(13)) comparable to the CHOOZ limit when |Delta m2|=2.43x10(-3) eV2 and sin2(2theta(23))=1.0 are assumed.
Collapse
|
92
|
Nasar-Abbas S, Siddique K, Plummer J, White P, Harris D, Dods K, D'Antuono M. Faba bean (Vicia faba L.) seeds darken rapidly and phenolic content falls when stored at higher temperature, moisture and light intensity. Lebensm Wiss Technol 2009. [DOI: 10.1016/j.lwt.2009.05.013] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
93
|
Wootton M, Harris D. Trampolining injuries presenting to a children's emergency department. Emerg Med J 2009; 26:728-31. [DOI: 10.1136/emj.2008.069344] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
94
|
Haygarth PM, Apsimon H, Betson M, Harris D, Hodgkinson R, Withers PJA. Mitigating diffuse phosphorus transfer from agriculture according to cost and efficiency. JOURNAL OF ENVIRONMENTAL QUALITY 2009; 38:2012-2022. [PMID: 19704144 DOI: 10.2134/jeq2008.0102] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Potential options for mitigating phosphorus (P) transfer from agriculture to water in England and Wales (E&W) were collated across a range of farm systems to assess their potential effectiveness in reducing mass of P transferred and potential cost (pounds sterling [ pound]) to the farming industry. A simple model framework (called PEASE) incorporating a number of assumptions was used to identify 15 methods for mitigating inputs of P to agricultural systems, 19 methods for preventing mobilization of P, and six methods for controlling the transport of P to streams. The scope for largest reductions in P inputs was to grassland and horticulture. Potential reductions in P mobilization were up to 1.2 kg P ha(-1). Reductions in P transfer associated with transport mitigation were larger than those associated with input and mobilization methods (up to 2.2 kg P ha(-1)). The largest estimated reductions were achieved by installing buffer zones and constructed wetlands, the former being very cost effective ( pound3-5 kg(-1) P saved). Plots of cost curves helped identify where the combined and cumulative P transfer reductions were attainable; these were approximately 0.2 kg ha(-1) for uplands, 0.6 kg ha(-1) for outdoor pigs, 0.9 kg ha(-1) for intensive dairy, and 2.2 kg ha(-1) for arable examples. We concluded that established catchment-scale evidence for mitigation is sparse, especially for specific farm systems in E&W. Sensitivities and uncertainties in the approach, especially associated with expert coefficients, are noted. This approach is nonetheless considered useful for prioritizing where and how best options might be most effectively targeted for least cost but greatest benefit.
Collapse
|
95
|
Gross AM, Diacon AH, van den Heuvel MM, Janse van Rensburg J, Harris D, Bolliger CT. Management of life-threatening haemoptysis in an area of high tuberculosis incidence. Int J Tuberc Lung Dis 2009; 13:875-880. [PMID: 19555538] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023] Open
Abstract
BACKGROUND Emergency admissions with life-threatening haemoptysis in an area of high tuberculosis (TB) incidence at the University of Stellenbosch and Tygerberg Academic Hospital, South Africa. It is unclear if lung resection is regularly indicated to prevent recurrence following bronchial artery embolisation (BAE). OBJECTIVE To prospectively evaluate risk factors for recurrence as selection criteria for surgery following embolisation: lack of complete cessation of haemoptysis, need for blood transfusion, presence of aspergilloma and absence of active TB. DESIGN Prospective interventional study with 1-year follow-up. RESULTS Within a 7-month period, 101 consecutive patients were admitted. Seven were excluded and 12 died shortly after admission. Haemoptysis ceased on medical treatment alone within 24 h in 21 of the remaining 82 patients. Their 1-year mortality was 10%. Eleven of 61 patients referred for emergency embolisation died before discharge. Of the 50 patients remaining at risk of recurrence, 38 (76%) were at low risk and 12 (24%) at high risk. Five of these patients (10% of those at risk) underwent surgery. Patients at low risk and operated patients had an uneventful course over 1 year, but two deaths occurred among the seven inoperable patients at high risk. CONCLUSION Lung resection surgery following successful BAE for life-threatening haemoptysis can safely be avoided in patients at low risk of recurrence.
Collapse
|
96
|
Adamson P, Aguilar-Arevalo AA, Anderson CE, Bazarko AO, Bishai M, Brice SJ, Brown BC, Bugel L, Cao J, Choudhary BC, Coney L, Conrad JM, Cox DC, Curioni A, Djurcic Z, Finley DA, Fleming BT, Ford R, Gallagher HR, Garcia FG, Garvey GT, Green C, Green JA, Harris D, Hart TL, Hawker E, Hylen J, Imlay R, Johnson RA, Karagiorgi G, Kasper P, Katori T, Kobilarcik T, Kopp S, Kourbanis I, Koutsoliotas S, Laird EM, Linden SK, Link JM, Liu Y, Liu Y, Loiacono L, Louis WC, Marchionni A, Mahn KBM, Marsh W, McGregor G, Messier MD, Metcalf W, Meyers PD, Mills F, Mills GB, Monroe J, Moore CD, Nelson JK, Nelson RH, Nguyen VT, Nienaber P, Nowak JA, Ouedraogo S, Patterson RB, Pavlovic Z, Perevalov D, Polly CC, Prebys E, Raaf JL, Ray H, Roe BP, Russell AD, Sandberg V, Schirato R, Schmitz D, Shaevitz MH, Shoemaker FC, Smart W, Smith D, Sodeberg M, Sorel M, Spentzouris P, Stancu I, Stefanski RJ, Sung M, Tanaka HA, Tayloe R, Tzanov M, Vahle P, Van de Water R, Viren B, Wascko MO, White DH, Wilking MJ, Yang HJ, Yumiceva FX, Zeller GP, Zimmerman ED, Zwaska R. Measurement of numicro and nue events in an off-axis horn-focused neutrino beam. PHYSICAL REVIEW LETTERS 2009; 102:211801. [PMID: 19519094 DOI: 10.1103/physrevlett.102.211801] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/12/2008] [Indexed: 05/27/2023]
Abstract
We report the first observation of off-axis neutrino interactions in the MiniBooNE detector from the NuMI beam line at Fermilab. The MiniBooNE detector is located 745 m from the NuMI production target, at 110 mrad angle (6.3 degrees) with respect to the NuMI beam axis. Samples of charged-current quasielastic numicro and nue interactions are analyzed and found to be in agreement with expectation. This provides a direct verification of the expected pion and kaon contributions to the neutrino flux and validates the modeling of the NuMI off-axis beam.
Collapse
|
97
|
Yap TA, Frentzas S, Tunariu N, Barriuso J, Harris D, Germuska M, Waghorne C, Li J, deSouza N, de Bono JS. Final results of a pharmacokinetic (PK) and pharmacodynamic (PD) phase I trial of ARQ 197 incorporating dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) studies investigating the antiangiogenic activity of selective c-Met inhibition. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.3523] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
3523 Background: ARQ 197 (ARQ) is a selective non-ATP competitive inhibitor of c-Met, a receptor tyrosine kinase implicated in tumor cell proliferation, invasion and angiogenesis. Preclinical data and declines in circulating endothelial cell (CEC) levels in patients (pts) receiving ARQ suggest antiangiogenic potential of c-Met inhibition. Methods: ARQ was administered orally twice daily (bid) to pts with advanced solid tumors. Pre and post-therapy tumor biopsies were mandated for c-Met and FAK immunohistochemical studies during dose escalation (n = 16). CEC enumeration was evaluated. 12 pts are being investigated in the maximum tolerated dose (MTD) expansion cohort with DCE and Diffusion Weighted (DW) MRI. Results: 29 pts (14 F/15 M; mean 54.4 yrs) received ARQ at doses of 100 (n = 3), 200 (n = 6), 300 (n = 16), and 400 (n = 4) mg bid. 3 pts experienced dose limiting toxicities of CTCAEv3 grade (G)3 fatigue (200 mg bid); G3 hand-foot syndrome, G3 mucositis and G3 febrile neutropenia (400 mg bid). This established the ARQ MTD/recommended phase II dose (RP2D) at 300 mg bid. Other toxicities were G1–2, such as fatigue (n = 5); diarrhea, nausea and vomiting (n = 3). Mean AUC0–12h and Cmax increased linearly through the MTD. Statistically significant post-ARQ inhibition of high baseline phosphorylated c-Met and FAK expression in tumor tissue was seen in all dose cohorts confirming target inhibition. Disease stabilization (SD) was seen in 11 pts for up to 23 weeks with tumor regressions up to 12.4%. 13 of 20 pts had post-ARQ CEC declines of up to 100%. In the DCE-MRI cohort to date, preliminary analyses of ktrans histograms from pelvic lesions were consistent with antiangiogenic effects, with a ktrans median reduction of 20.1% on day 7 of ARQ (intrapatient baseline variability: 2.8%). This effect was still present (ktrans median decline: 8.3%) on day 56 of ARQ. Conclusions: ARQ is well tolerated with MTD/RP2D of 300mg bid, linear PK and evidence of phosphorylated c-Met and FAK inhibition. CEC and preliminary DCE-MRI data support the antiangiogenic effects of c-Met inhibition with ARQ. Correlation with other DCE parameters and DW changes will be presented. [Table: see text]
Collapse
|
98
|
Frentzas SN, Groves MD, Barriuso J, Harris D, Reardon D, Curtis MC, Suttle AB, Ma B, Lager JJ, de Bono JS. Pazopanib and lapatinib in patients with relapsed malignant glioma: Results of a phase I/II study. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.2040] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
2040 Background: Pazopanib (paz) is an oral angiogenesis inhibitor targeting VEGFR, PDGFR, and c-kit; and lapatinib (lap) is an oral tyrosine kinase inhibitor of EGFR (ErbB1) and HER-2 (ErbB2). Combination of VEGFR, PDGFR, and ErbB1 inhibitors may provide synergistic antitumor activity in malignant glioma. Phase I determined the optimally tolerated regimen (OTR) of paz and lap when given with enzyme-inducing anticonvulsants (EIACs). Phase II, which evaluated the efficacy of daily paz/lap (400 mg/1000mg) in relapsed grade 4 glioma without EIACs, was previously reported. Methods: Patients (pts) with grade 3 or 4 glioma, on EIACs, and with adequate organ function were eligible. Doses of paz and lap were escalated in a 3 + 3 design. OTR was defined as the highest dose of paz/lap at which no more than 1 of 6 pts had dose limiting toxicity (DLT) and target concentrations were achieved. Results: 32 pts have been enrolled at doses of paz/lap (mg, daily unless specified) of 200/1500 (N = 4), 800/1500 (N = 6), 800/500 bid (N = 5), 800/750 bid (N = 7), 800/1000 bid (N = 6), and 600 bid/1000 bid (N = 4). Data on 28 pts: the most common adverse events (AEs) were: fatigue (25%); diarrhea (25%); headache (21%); ALT increase (18%); nausea (18%); and insomnia (14%). Hepatobiliary lab abnormalities were reversible, uncomplicated, and included: AST elevation (11%), hyperbilirubinemia (7%), ALT elevation (36%; 7% Gr 3), and Alk phos elevation (14%). DLTs were elevated liver enzymes (800/1500; 1 pt), elevated lipase (800/750 bid; 1 pt) and thrombocytopenia, fatigue, diarrhea, confusion (800/1000 bid; 1 pt). 2 pts dose reduced and 3 pts had a dose interruption. At 600 bid/1000 bid, the target paz Cmin of 17.5 μg/mL was achieved; median lap Cmin of 0.447 μg/mL approached the target of 0.5 μg/mL. Phase I best response (MacDonald criteria) was PR in 3 pts (11%) and SD ≥ 8 weeks in 5 pts (18%). Two pts remain on the phase II, at 21 months (PR) and 23 months (CR) of therapy. Conclusions: The paz/lap combination has a manageable safety profile with a preliminary OTR with EIACs of paz 600 mg bid/ lap 1000 mg bid. EIACs decreased plasma paz and lap concentrations. Responses and lengthy periods without disease progression were seen in some pts in phase I and II. [Table: see text]
Collapse
|
99
|
Davies M, Harris D, Hirst G, Beynon R, Morgan AR, Carr ND, Beynon J, Beynon J. Local recurrence after abdomino-perineal resection. Colorectal Dis 2009; 11:39-43. [PMID: 19076836 DOI: 10.1111/j.1463-1318.2008.01520.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
OBJECTIVE Local recurrence of rectal cancer is a major cause of morbidity and mortality following curative resection. The published rates vary after abdomino-perineal resection (APR) from 5% to 47%. The aim of this study was to evaluate local recurrence following curative APR for low rectal cancer in our unit. METHOD The medical notes of patients treated between 1st January 1996 and 31st December 2000 were retrieved. Local recurrence was defined as the presence of tumour within the pelvis confirmed by clinical findings, pathological specimen or radiological reports. A curative resection was defined as excision of tumour in the absence of macroscopic metastatic disease and whose resection margins were greater than 1 mm circumferentially and 10 mm distally. Outcomes and survival were compared using Fisher's exact test and Kaplan-Meier method. RESULTS Two hundred consecutive cases with a diagnosis of rectal cancer were identified of which 139 underwent a curative resection (69.5%). Of these 40 patients (28%) underwent APR with curative intent. Two patients (5%) developed local recurrence at 18 and 24 months respectively. The overall local recurrence rate for all curative rectal cancer surgery, in the same period was 2.6%. Eleven patients have died in the follow-up period of which nine were cancer-related deaths. CONCLUSION The local recurrence rates achieved with APR were not significantly different from those achieved with restorative operations. Tumours at the ano-rectal junction should not be dissected off the pelvic floor, but radically excised en bloc with the surrounding levator ani, as a cylinder, as originally described by Miles.
Collapse
|
100
|
Kool DM, Wrage N, Oenema O, Harris D, Van Groenigen JW. The 18O signature of biogenic nitrous oxide is determined by O exchange with water. RAPID COMMUNICATIONS IN MASS SPECTROMETRY : RCM 2009; 23:104-108. [PMID: 19061209 DOI: 10.1002/rcm.3859] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
To effectively mitigate emissions of the greenhouse gas nitrous oxide (N(2)O) it is essential to understand the biochemical pathways by which it is produced. The (18)O signature of N(2)O is increasingly used to characterize these processes. However, assumptions on the origin of the O atom and resultant isotopic composition of N(2)O that are based on reaction stoichiometry may be questioned. In particular, our deficient knowledge on O exchange between H(2)O and nitrogen oxides during N(2)O production complicates the interpretation of the (18)O signature of N(2)O.Here we studied O exchange during N(2)O formation in soil, using a novel combination of (18)O and (15)N tracing. Twelve soils were studied, covering soil and land-use variability across Europe. All soils demonstrated the significant presence of O exchange, as incorporation of O from (18)O-enriched H(2)O into N(2)O exceeded their maxima achievable through reaction stoichiometry. Based on the retention of the enrichment ratio of (18)O and (15)N of NO(3)(-) into N(2)O, we quantified O exchange during denitrification. Up to 97% (median 85%) of the N(2)O-O originated from H(2)O instead of from the denitrification substrate NO(3)(-).We conclude that in soil, the main source of atmospheric N(2)O, the (18)O signature of N(2)O is mainly determined by H(2)O due to O exchange between nitrogen oxides and H(2)O. This also challenges the assumption that the O of N(2)O originates from O(2) and NO(3)(-), in ratios reflecting reaction stoichiometry.
Collapse
|